Glaxosmithkline PLC, 10% Owner at Translate Bio, Inc. (TBIO), bought 1,569,346 shares at $13.00 ($3.5M) on 2018-07-02, disclosed to the SEC on 2018-07-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,300,116 | $0 | 0.0% |
| 2 | $13.00 | 269,230 | $3.5M | 100.0% |
| Total | $2.23 avg | 1,569,346 | $3.5M | 100% |
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |